← Leaderboards
Yong Chan Kim
Teraimmune, Inc.
$224,941
Attributed
$224,941
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$224,941 · 1
By mechanism
R43$224,941 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alternative Treatment”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Christopher Barnaby Nelson · University Of Melbourne$26,782,982
- Craig Reist · Research Triangle Institute$22,725,934
- Lisa Newman · Research Triangle Institute$22,725,934
- Gary Fanger · Rise Therapeutics, Llc$9,510,819
Research focus
Alternative TreatmentAntibodiesAntibody InhibitorAntibody ResponseAutoimmune DiseasesAutologousBaseBlood CoagulationBlood Coagulation DisordersBlood Coagulation FactorB-LymphocytesCellsCell TherapyChildChimeric Antigen ReceptorClinicClinical ApplicationClinical DevelopmentClinical ProtocolsClinical TrialsCloningCoagulation ProcessCollaborationsAdverse Event